DUTALOSIN (KSJ Pharmatech)
Product name
DUTALOSIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
165 (255 working days)
Active ingredients
dutasteride, tamsulosin hydrochloride
Registration type
New generic medicine
Indication
DUTASTERIDEis indicated for the management of moderate to severe symptomatic benign prostatic hyperplasia (BPH).